Bioneutra Internatio Financials

BIMO Stock  USD 0.0001  0.00  0.00%   
Based on the analysis of Bioneutra Internatio's profitability, liquidity, and operating efficiency, Bioneutra Internatio is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.
  
Understanding current and past Bioneutra Internatio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioneutra Internatio's financial statements are interrelated, with each one affecting the others. For example, an increase in Bioneutra Internatio's assets may result in an increase in income on the income statement.

Bioneutra Internatio Stock Summary

Bioneutra Internatio competes with Diageo PLC, Safety Shot, Siriuspoint, Brandywine Realty, and Root. SuperVision Entertainment, Inc. provides hi tech alternate power systems and environment products. SuperVision Entertainment, Inc. was incorporated in 1984 and is based in Edmonton, Canada. Bioneutra International is traded on OTC Exchange in the United States.
Specialization
Industrials, Capital Goods
InstrumentUSA Stock View All
ExchangeOTCCE Exchange
ISINUS0906201050
Business AddressP O Box
SectorIndustrial Conglomerates
IndustryIndustrials
BenchmarkDow Jones Industrial
Phone780 443 2301
CurrencyUSD - US Dollar

Bioneutra Internatio Key Financial Ratios

Bioneutra Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bioneutra Internatio's current stock value. Our valuation model uses many indicators to compare Bioneutra Internatio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioneutra Internatio competition to find correlations between indicators driving Bioneutra Internatio's intrinsic value. More Info.
Bioneutra Internatio is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about  10,001  of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioneutra Internatio's earnings, one of the primary drivers of an investment's value.

Bioneutra Internatio Systematic Risk

Bioneutra Internatio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioneutra Internatio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Bioneutra Internatio correlated with the market. If Beta is less than 0 Bioneutra Internatio generally moves in the opposite direction as compared to the market. If Bioneutra Internatio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioneutra Internatio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioneutra Internatio is generally in the same direction as the market. If Beta > 1 Bioneutra Internatio moves generally in the same direction as, but more than the movement of the benchmark.
When determining whether Bioneutra Internatio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioneutra Internatio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioneutra Internatio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioneutra Internatio Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioneutra Internatio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Bioneutra Stock, please use our How to Invest in Bioneutra Internatio guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Industrial Conglomerates space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioneutra Internatio. If investors know Bioneutra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioneutra Internatio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioneutra Internatio is measured differently than its book value, which is the value of Bioneutra that is recorded on the company's balance sheet. Investors also form their own opinion of Bioneutra Internatio's value that differs from its market value or its book value, called intrinsic value, which is Bioneutra Internatio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioneutra Internatio's market value can be influenced by many factors that don't directly affect Bioneutra Internatio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioneutra Internatio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioneutra Internatio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioneutra Internatio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.